Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (11-20 of 283) with videos related to

Pageof 29
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2016
Predictive Markers for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Lung CancerTakehito Shukuya, David P Carbone
Advances in Cancer Research|November 9, 2004
Tumor-host immune interactions and dendritic cell dysfunctionLi Yang, David P Carbone
Cancer Journal (Sudbury, Mass.)|May 28, 2013
From the guest editors: management of locally advanced lung cancerDavid P Carbone, Arnab Chakravarti
Respirology (Carlton, Vic.)|January 9, 2007
Proteomics analysis in lung cancer: challenges and opportunitiesTakefumi Kikuchi, David P Carbone
Respiratory Research|December 4, 2003
The molecular basis of lung cancer: molecular abnormalities and therapeutic implicationsPierre P Massion, David P Carbone
Nature Reviews. Clinical Oncology|February 1, 2011
Lung cancer in 2010: One size does not fit allChristine M Lovly, David P Carbone
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Molecular staging and pharmacogenomics. Clinical implications: from lab to patients and backWilbur A Franklin, David P Carbone
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Lung cancer vaccines and gene therapyKristen M Hege, David P Carbone
Oncology (Williston Park, N.Y.)|February 7, 2002
Immune dysfunction in cancer patientsJoyce E Ohm, David P Carbone
Translational Lung Cancer Research|December 9, 2017
Blood-based biomarkers in lung cancer: prognosis and treatment decisionsMeng Xu-Welliver, David P Carbone
Pageof 29

Showing results (11-20 of 283) with videos related to

Sort By:
Pageof 29
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2016
Predictive Markers for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Lung CancerTakehito Shukuya, David P Carbone
Advances in Cancer Research|November 9, 2004
Tumor-host immune interactions and dendritic cell dysfunctionLi Yang, David P Carbone
Cancer Journal (Sudbury, Mass.)|May 28, 2013
From the guest editors: management of locally advanced lung cancerDavid P Carbone, Arnab Chakravarti
Respirology (Carlton, Vic.)|January 9, 2007
Proteomics analysis in lung cancer: challenges and opportunitiesTakefumi Kikuchi, David P Carbone
Respiratory Research|December 4, 2003
The molecular basis of lung cancer: molecular abnormalities and therapeutic implicationsPierre P Massion, David P Carbone
Nature Reviews. Clinical Oncology|February 1, 2011
Lung cancer in 2010: One size does not fit allChristine M Lovly, David P Carbone
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Molecular staging and pharmacogenomics. Clinical implications: from lab to patients and backWilbur A Franklin, David P Carbone
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Lung cancer vaccines and gene therapyKristen M Hege, David P Carbone
Oncology (Williston Park, N.Y.)|February 7, 2002
Immune dysfunction in cancer patientsJoyce E Ohm, David P Carbone
Translational Lung Cancer Research|December 9, 2017
Blood-based biomarkers in lung cancer: prognosis and treatment decisionsMeng Xu-Welliver, David P Carbone
Pageof 29